News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
353,390 Results
Type
Article (21728)
Company Profile (164)
Press Release (331498)
Section
Business (111080)
Career Advice (913)
Deals (19726)
Drug Delivery (91)
Drug Development (52555)
Employer Resources (86)
FDA (8091)
Job Trends (8104)
News (195184)
Policy (18084)
Tag
Academia (837)
Alliances (28895)
Alzheimer's disease (622)
Approvals (8052)
Artificial intelligence (88)
Bankruptcy (181)
Best Places to Work (5689)
Biosimilars (68)
Biotechnology (82)
Breast cancer (54)
Cancer (516)
Career advice (743)
Cell therapy (76)
Clinical research (42935)
Collaboration (190)
Compensation (70)
COVID-19 (1136)
C-suite (59)
Data (536)
Diabetes (88)
Diagnostics (1920)
Drug pricing (91)
Earnings (39505)
Employer resources (80)
Events (54933)
Executive appointments (179)
FDA (8331)
Funding (144)
Gene therapy (87)
GLP-1 (483)
Government (1865)
Healthcare (6834)
Infectious disease (1183)
Inflammatory bowel disease (70)
Interviews (124)
IPO (8024)
Job creations (2621)
Job search strategy (679)
Layoffs (269)
Legal (4407)
Lung cancer (92)
Manufacturing (121)
Medical device (2639)
Medtech (2642)
Mergers & acquisitions (11733)
Metabolic disorders (308)
Neuroscience (776)
NextGen Class of 2024 (2623)
Non-profit (1163)
Northern California (625)
Obesity (202)
Opinion (174)
Patents (68)
People (35278)
Pharmaceutical (77)
Phase I (13378)
Phase II (18267)
Phase III (14533)
Pipeline (172)
Podcasts (54)
Policy (67)
Postmarket research (1692)
Preclinical (4864)
Radiopharmaceuticals (167)
Rare diseases (138)
Real estate (3495)
Regulatory (12505)
Research institute (917)
Resumes & cover letters (144)
Southern California (592)
Startups (2228)
United States (6250)
Vaccines (227)
Weight loss (179)
Date
Today (123)
Last 7 days (504)
Last 30 days (1750)
Last 365 days (19490)
2024 (16973)
2023 (21517)
2022 (28153)
2021 (28718)
2020 (26696)
2019 (22093)
2018 (17048)
2017 (18389)
2016 (17514)
2015 (20309)
2014 (16014)
2013 (13593)
2012 (14609)
2011 (14878)
2010 (13688)
Location
Africa (424)
Asia (25119)
Australia (3351)
California (1413)
Canada (717)
China (131)
Colorado (57)
Connecticut (58)
Europe (52824)
Florida (183)
Illinois (136)
Indiana (114)
Kansas (55)
Maryland (219)
Massachusetts (1678)
Minnesota (84)
New Jersey (529)
New York (416)
North Carolina (360)
Northern California (625)
Ohio (65)
Pennsylvania (355)
South America (636)
Southern California (592)
Texas (173)
Washington State (136)
353,390 Results for "boston pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Institute of Biotechnology & BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award
September 11, 2024
·
3 min read
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
·
2 min read
·
Tristan Manalac
Business
Boston Pharmaceuticals Appoints Dr. Margaret Koziel as New Chief Medical Officer
Boston Pharmaceuticals today announced the appointment of Margaret Koziel, M.D., as Chief Medical Officer (CMO). Juan Carlos Lopez-Talavera, M.D., Ph.D., who has served as acting CMO since December 2023, will move to an advisory role to Dr. Koziel and the Boston Pharmaceuticals team as the company advances its promising late-stage candidate BOS-580.
June 6, 2024
·
4 min read
Business
Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors
Boston Pharmaceuticals has today named Dr. Elias Zerhouni as the new Chair of its Board of Directors, with Stefan Meister standing down from the Board after six years to focus on his ongoing roles elsewhere.
May 23, 2024
·
3 min read
Business
Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal
Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.
May 23, 2024
·
2 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Genetown
Boston Pharmaceuticals Presents Data at EASL Congress 2024 Showing Treatment With Long-acting FGF21 Analogue, BOS-580, Improved Lipid Profiles in Patients with Phenotypic MASH
Boston Pharmaceuticals today announced new Phase 2a data demonstrating the positive impact of BOS-580, an investigational, long-acting fibroblast growth factor 21 (FGF21) analogue, on the circulating lipidome and changes in the metabolomics advanced steatohepatitis fibrosis (MASEF) score in patients with phenotypic metabolic dysfunction-associated steatohepatitis (MASH).
June 5, 2024
·
5 min read
Pharm Country
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new analyses of data from its Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials have been accepted for presentation in two posters at the 2024 Annual Meeting of the Endocrine Society (ENDO), to be held in Boston, MA June 1-4, 2024.
May 20, 2024
·
1 min read
Layoffs
Athira Pharma to Lay Off 70% of Workforce
Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s disappointing results for its investigational Alzheimer’s therapy.
September 23, 2024
·
1 min read
·
Angela Gabriel
Drug Development
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of new analyses of data from its Phase 2 OraGrowtH212 clinical trial presented in two posters at the 2024 Annual Meeting of the Endocrine Society (ENDO), held in Boston, MA, June 1-4, 2024.
June 4, 2024
·
7 min read
1 of 35,339
Next